Semler Scientific, Inc. (SMLR)
NASDAQ: SMLR · Real-Time Price · USD
40.00
-0.08 (-0.20%)
At close: May 30, 2025, 4:00 PM
39.51
-0.49 (-1.23%)
After-hours: May 30, 2025, 7:32 PM EDT
Semler Scientific Revenue
Semler Scientific had revenue of $8.84M in the quarter ending March 31, 2025, a decrease of -44.44%. This brings the company's revenue in the last twelve months to $49.23M, down -25.28% year-over-year. In the year 2024, Semler Scientific had annual revenue of $56.29M, down -17.44%.
Revenue (ttm)
$49.23M
Revenue Growth
-25.28%
P/S Ratio
6.42
Revenue / Employee
$623,114
Employees
79
Market Cap
446.06M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.29M | -11.89M | -17.44% |
Dec 31, 2023 | 68.18M | 11.50M | 20.28% |
Dec 31, 2022 | 56.69M | 3.66M | 6.90% |
Dec 31, 2021 | 53.03M | 14.42M | 37.36% |
Dec 31, 2020 | 38.60M | 5.84M | 17.81% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
SMLR News
- 12 hours ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Semler Scientific, Inc. (SMLR) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Encourages Semler Scientific, Inc. (SMLR) Investors to Inquire about Securities Investigation - Accesswire
- 2 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Semler Scientific, Inc. (SMLR) And Encourages Investors to Reach Out - Accesswire
- 11 days ago - Wolf Haldenstein Adler Freeman & Herz LLP is investigating Semler Scientific Inc. - PRNewsWire
- 11 days ago - Semler Scientific® Appoints Natalie Brunell to its Board of Directors - PRNewsWire
- 14 days ago - Wolf Haldenstein Adler Freeman & Herz LLP is investigating Semler Scientific Inc. (NASDAQ: SMLR) for potential violations of securities laws - GlobeNewsWire
- 17 days ago - Semler Scientific, Inc. (SMLR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Semler Scientific® Reports First Quarter 2025 Financial Results, BTC Yield of 22.2% YTD; Now holds 3,808 BTC - PRNewsWire